UNIBA Hypertension With Jnc7 and Mnt 28-6-12

Embed Size (px)

Citation preview

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    1/65

    Hypertension: Medical Management

    and Nutritional Approaches

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    2/65

    Circuits

    Pulmonary circuitThe blood pathway

    between the right side of the

    heart, to the lungs, and back

    to the left side of the heart.

    Systemic circuit

    The pathway between the

    left and right sides of theheart.

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    3/65

    Distribution of Blood in the Body Organs

    Figure 15-13: Distribution of blood in the body at rest

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    4/65

    Regulation of Blood Pressure

    Figure 15-22: The baroreceptor reflex: the response to increased blood pressure

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    5/65

    Baroreceptor and ChemoreceptorReflexes

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    6/65

    Hypertension

    Persistently high arterial blood

    pressure

    Systolic blood pressure above 140

    mm Hg and/or diastolic blood

    pressure above 90 mm Hg

    Normotensive = 120/80 mm Hg

    Prehypertensive = 120139/80-89

    mm Hg

    Stage 1 hypertension = 140159/90-

    99 mm Hg

    Stage 2 hypertension = >160/>100

    mm Hg

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    7/65

    Prevalence and Incidence

    29% of adult US population

    Related to body mass index

    High prevalence in African Americans

    5% of pediatric population; prevalence increases

    with age

    Strong positive relationship between blood pressure

    and risk of CVD events

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    8/65

    Pathophysiology

    Blood pressure is a function of cardiac output

    multiplied by peripheral resistance

    Affected by diameter of blood vessel

    Atherosclerosis decreases diameter, increases bloodpressure

    Drug therapy increases diameter, lowers blood

    pressure

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    9/65

    Circulatory Systems in the Body

    1. Coronarysupplies blood to heartmuscle (can form collateralcirculation)

    2. Cerebralsupplies blood to head3. Splanchnicsupplies blood to

    abdomen (exercise removes blood

    and food attracts blood to this area)4. Pulmonarysupplies blood to lungs

    (O2 and CO2 exchange)

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    10/65

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    11/65

    Determinants of Blood Pressure

    1. Blood volume

    2. Vascular resistance to pressure

    3. Heart stroke volume

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    12/65

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    13/65

    Vascular Resistance

    Viscosity of blood

    Width of vessels(constriction or

    dilation)controlled by muscle tone invessel walls

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    14/65

    Regulation of Blood Pressure

    1. Sympathetic nervous system (SNS)respondsimmediately; baroreceptors monitor BP

    Vasomotor center in brain

    SNS innervated tissues contract or dilate vascularbed

    2. Renin-angiotensin systemretains Na and H2O to

    increase blood volume; constricts blood vessels;increases aldosterone

    3. Kidneysrespond to renin-angiotensin system;aldosterone and antidiuretic hormone (ADH) are sent

    out as needed

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    15/65

    Homeostatic Control ofBlood Pressure

    Short term

    Sympathetic nervous system

    VasoconstrictionVasodilation

    Long term

    Fluid volumeRenin-angiotensin system

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    16/65

    Hypertension

    1. 90% HTN is essential HTN (cause unknown;

    perhaps prenatal impacts?)

    2. 10% HTN is secondary to other diseases

    3. HTN is a risk factor for MI, CVA, renal failure

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    17/65

    Renin-Angiotensin Cascade

    Redrawn from Guyton AC: Textbook of medical physiology, ed 8, Philadelphia, 1991, WB Saunders.

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    18/65

    Causes of Hypertension

    Algorithm content developed by John Anderson, PhD, and Sanford C. Garner, PhD, 2000.

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    19/65

    Identifiable causes of hypertension Chronic kidney disease\

    Coarctation of the Aorta Cushings Syndrome

    Drug induced

    Obstructive uropathy

    Pheochromocytoma Primary aldosteronism and other mineralocorticoid excess

    states

    Renovascular HTN stenosis and fibromuscular dysplasia

    Sleep Apnea Thyroid (either HYPER or HYPO) or parathyroid disease

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    20/65

    Risk Factors for Developing

    Hypertension

    (Adapted from National High Blood Pressure Education Program Working Group report on primary prevention of hypertension.

    Arch Intern Med 153:186, 1993. Copyright 1993, American Medical Association. Reprinted with permission.)

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    21/65

    Risk Stratification in Patients with

    Hypertension

    (From The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. sixth report

    (JNC VI). Arch Intern Med 157:2413, 1997.)

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    22/65

    Uncontrolled Hypertension

    Leads to increased

    Workload on heart

    Damage to arteries

    Atherosclerosis

    Coronary heart disease esp. CHF

    Strokes

    Transient ischemic attacks (TIAs)

    Kidney damage

    Microvascular hemorrhages in brain and eye

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    23/65

    The DASH Diet Trials

    Randomized feeding trial comparing effects of 3 diet

    patterns: control, high fruits/vegetables, and high

    fruits/vegetables/whole grains/lowfat dairy (DASH diet)

    DASH diet high in potassium, magnesium, calcium,fiber and low in fat, saturated fat, and cholesterol

    DASH diet significantly lowered BP in all groups, but

    especially in African-Americans

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    24/65

    Effects of Diet on BP (DASH Trial)

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    25/65

    For persons over age 50, SBP is a more important

    than DBP as CVD risk factor.

    Persons who are normotensive at age 55 have a 90%

    lifetime risk for developing HTN.

    Those with SBP 120139 mmHg or DBP 8089 mmHg

    should be considered prehypertensive who require

    health-promoting lifestyle modifications to prevent

    CVD.

    New Features and Key Messages

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    26/65

    New Features and Key Messages(Continued)

    Thiazide-type diuretics should be initial drug therapy for

    most, either alone or combined with other drug classes.

    Certain high-risk conditions are compelling indications forother drug classes.

    Most patients will require two or more antihypertensive

    drugs to achieve goal BP.

    If BP is >20/10 mmHg above goal, initiate therapy with two

    agents, one usually should be a thiazide-type diuretic.

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    27/65

    Blood Pressure Classification

    Normal 100

    BP Classification SBP mmHg DBP mmHg

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    28/65

    CVD Risk

    HTN prevalence ~ 50 million people in the United States.

    The BP relationship to risk of CVD is continuous, consistent,

    and independent of other risk factors.

    Each increment of 20/10 mmHg doubles the risk of CVD

    across the entire BP range starting from 115/75 mmHg.

    Prehypertension signals the need for increased education to

    reduce BP in order to prevent hypertension.

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    29/65

    Benefits of Lowering BP

    Average Percent Reduction

    Stroke incidence 3540%

    Myocardial infarction 2025%

    Heart failure 50%

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    30/65

    BP Control Rates

    Trends in awareness, treatment, and control of highblood pressure in adults ages 1874

    National Health and Nutrition Examination Survey, Percent

    II

    197680

    II(Phase 1)

    198891

    II(Phase 2)

    199194 19992000

    Awareness 51 73 68 70

    Treatment 31 55 54 59

    Control 10 29 27 34

    Sources: Unpublished data for 19992000 computed by M. Wolz, National Heart, Lung, and Blood Institute; JNC 6.

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    31/65

    BP Measurement Techniques

    Method Brief Description

    In-office Two readings, 5 minutes apart, sitting in

    chair. Confirm elevated reading in

    contralateral arm.Ambulatory BP monitoring Indicated for evaluation of white-coat HTN.

    Absence of 1020% BP decrease during

    sleep may indicate increased CVD risk.

    Self-measurement Provides information on response to therapy.May help improve adherence to therapy and

    evaluate white-coat HTN.

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    32/65

    CVD Risk Factors

    Microalbuminuria orestimated GFR 30 kg/m2)

    Physical inactivity

    Dyslipidemia*

    Diabetes mellitus*

    *Components of the metabolic syndrome.

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    33/65

    Target Organ Damage

    Heart Left ventricular hypertrophy

    Angina or prior myocardial infarction

    Prior coronary revascularization

    Heart failure

    Brain

    Stroke or transient ischemic attack

    Chronic kidney disease

    Peripheral arterial disease

    Retinopathy

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    34/65

    Goals of Therapy

    Reduce CVD and renal morbidity and mortality.

    Treat to BP

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    35/65

    Lifestyle Modification

    Modification Approximate SBP reduction

    (range)

    *Weight reduction 520 mmHg/10 kg weight loss

    *Adopt DASH eating plan 814 mmHg

    *Dietary sodium reduction 28 mmHg

    Physical activity 49 mmHg

    *Moderation of alcohol

    consumption

    24 mmHg

    *medical nutrition therapy interventions

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    36/65

    Classification ofAntihypertensive Drugs

    Diuretics

    Thiazides

    Loop diuretics

    Potassium-sparing diuretics Beta blockers (BB)

    Angiotensin II receptor blockers (ARBs)

    Alpha-beta blockers

    Alpha1 receptor blockers ACE inhibitors (angiotensin converting enzyme)

    Calcium antagonists

    Direct vasodilators

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    37/65

    Algorithm for Treatment of Hypertension

    Not at Goal Blood Pressure (100 mmHg)

    2-drug combination for most (usually

    thiazide-type diuretic and

    ACEI, or ARB, or BB, or CCB)

    Stage 1 Hypertension(SBP 140159 or DBP 9099 mmHg)

    Thiazide-type diuretics for most.

    May consider ACEI, ARB, BB, CCB,

    or combination.

    Without CompellingIndications

    Not at Goal

    Blood Pressure

    Optimize dosages or add additional drugs

    until goal blood pressure is achieved.

    Consider consultation with hypertension specialist.

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    38/65

    Compelling Indications

    These are reasons for using a particular class ofmedications

    For example, patients with diabetes, kidney damage,and high blood pressure should begin treatment with

    ACE inhibitors.

    Heart attack (in conjunction with hypertension) is acompelling indication for the prescription of beta-blockers and, in certain instances, ACE inhibitors

    Heart failure should first be treated with ACE inhibitorsand diuretics.

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    39/65

    Classification and Managementof BP for adults

    BP

    classification

    SBP*

    mmHg

    DBP*

    mmHg

    Lifestyle

    modification

    Initial drug therapy

    Without compelling

    indication

    With compelling

    indications

    Normal 100 Yes Two-drug combination for

    most (usually thiazide-type

    diuretic and ACEI or ARB or

    BB or CCB).

    *Treatment determined by highest BP category.Initial combined therapy should be used cautiously in those at risk for orthostatic hypotension.

    Treat patients with chronic kidney disease or diabetes to BP goal of

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    40/65

    Minority Populations

    In general, treatment similar for all demographic groups.

    Socioeconomic factors and lifestyle important barriers to BP control.

    Prevalence, severity of HTN increased in African Americans.

    African Americans demonstrate somewhat reduced BP responses to

    monotherapy with BBs, ACEIs, or ARBs compared to diuretics or

    CCBs.

    These differences usually eliminated by adding adequate doses of a

    diuretic.

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    41/65

    Children and Adolescents

    HTN defined as BP95th percentile or greater, adjusted for age,

    height, and gender.

    Use lifestyle interventions first, then drug therapy for higher levels ofBP or if insufficient response to lifestyle modifications.

    Drug choices similar in children and adults, but effective doses are

    often smaller.

    Uncomplicated HTN not a reason to restrict physical activity.

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    42/65

    Lifestyle Modifications

    Sodium: not more than 2.4 grams sodium/day

    Activity: activity like brisk walking 30 minutes/day most

    days of the week

    Alcohol: not more than 1 drink a day for women; 2drinks a day for men

    DASH diet: low in sodium, high in potassium, calcium,

    cholesterol, saturated fat

    Weight: weight loss of as little as 10 lb can prevent or

    treat high blood pressure

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    43/65

    Weight Management

    Risk of developing high blood pressure is 2-6 times

    higher in overweight than normal weight persons

    20-30% of the hypertension in the US is attributable to

    excess weight In Framingham, weight increase of 10% predicted rise

    in blood pressure of 7 mm/hg

    Weight gain during adult life is responsible for much of

    the rise in blood pressure seen with aging

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    44/65

    Weight Management

    Excess body weight may increase blood pressurethrough increased insulin resistance andhyperinsulinemia, activation of the sympathetic nervousand renin-angiotensin systems, and changes in the

    kidney Weight loss lowers vascular resistance, total blood

    volume, cardiac output, and sympathetic nervoussystem activity; improves insulin resistance

    Weight loss in an overweight person is the single mosteffective lifestyle intervention to reduce blood pressure

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    45/65

    Weight Management

    In the Trial of Antihypertensive Intervention and

    Management, goal for energy intake to facilitate weight

    loss was 25 kcals/kg minus 500 to 1000 kcal daily to

    produce a .5 to 1 kg weight loss/week to achieve totalweight loss of 4.5 kg.

    Wylie-Rosett et al, 1993

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    46/65

    Sodium and Hypertension

    Relationship between sodium and hypertension is strongerin

    Older people

    Those with a family history of hypertension Those with higher blood pressures at baseline

    30-50% of hypertensives and 15-25% of normotensivesare salt sensitive

    Salt sensitivity more common in black race, obesity,advanced age, diabetes, renal dysfunction, use ofcyclosporine

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    47/65

    Sodium and Hypertension

    Addition of a sodium restriction to a DASH diet lowers

    SBP 3 mmHg and DBP 2 mmHg

    This reduction is associated with a 17% reduction in

    prevalence of hypertension, 6% reduction in CHD, 15%reduction in stroke and TIA

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    48/65

    Salt Restriction

    Recommendation is for moderate salt restriction (6

    grams salt, 100 mEq or 2400 mg Na daily)

    Salt is the issue, because chloride ion with sodium

    raises blood pressure May normalize blood pressure in Stage 1 hypertension

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    49/65

    Levels of Na Restriction

    g Na mEq Na Description

    4 174 No added salt

    2-3 87-130 Mild to moderate

    restriction1 43 Strict sodium restriction

    0.5 22 Severe sodium restriction

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    50/65

    Alcohol and Hypertension

    5-7% of hypertension is due to alcohol

    consumption

    3 drinks per day is the threshold for raisingblood pressure; associated with a 3 mmHg

    increase

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    51/65

    Physical Activity and Hypertension

    Less active persons are 30-50% more likely to develop

    hypertension than active persons

    Medium to high levels of activity protective against

    stroke (Framingham) Walking reduces blood pressure in adults by an

    average of 2%

    In a meta-analysis of 54 randomized trials, walking

    reduced blood pressure an average of 4 mmHg,

    irrespective of weight change

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    52/65

    Potassium

    In population studies, potassium intake and blood

    pressure are inversely related

    Sodium/potassium ratio is important

    Sodium/potassium ratio of 1:1 a 3.4 mmHg decrease insystolic BP is predicted

    High potassium intake inversely related to stroke

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    53/65

    Other Factors

    Calcium, Magnesium, and Lipids: role still unclear

    DASH diet high in lowfat dairy products

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    54/65

    Response to Dietary Rx

    Salt sensitive respond well to sodium restriction

    Most respond to increased potassium in diet.

    1.1 to 3.3 g Na is safe

    1.9 to 5.6 g K is recommended to achieve ratio Na:K of1, which is goal

    If taking a potassium-wasting diuretic drug, increasedpotassium in diet is essential.

    Most respond to increased calcium (at least the RDA)usethe DASH diet protocol

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    55/65

    DASH Diet

    Works within 14 days

    Lowers BP quite well

    Includes more potassium, calcium,

    other nutrients

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    56/65

    DASH Fact Sheet

    www.nhlbi.nih.gov/heal

    th/public/heart/hbp/dash/

    new_dash.pdf

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    57/65

    DASH Diet contd

    Pattern

    7-8 whole grains

    4-5 vegetables

    4-5 fruits

    2-3 low-fat or fat-free dairy products

    6 oz or less meat/poultry/fish

    4-5 servings nuts, beans, or legumes/week2-3 servings fat (total kcal = 27% fat)

    DASH Diet Patterns for

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    58/65

    DASH Diet Patterns forDifferent Calorie Levels

    Kcals Grain Veg Fruit Dairy Meat/

    Pro

    Nuts/

    Legume

    Fats/

    oils

    1600 6 4 4 2 1 .5 1

    2000 8 5 5 3 2 1 2

    2600 10 5 5 3 2 1 2

    3100 13 6 6 4 2 1 3

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    59/65

    Sodium

    Processed and restaurant foods provide 80% of sodiumintake

    Read labels; sodium content of different brands varies

    10% added in cooking at home and at table; 10% naturally

    occurring Americans consume ~4,000 mg/day; 2005 Dietary Guidelines

    for Americans recommend

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    60/65

    Food Label Terms

    Sodium free, no sodium =

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    61/65

    Salt Substitutes

    Composition: KCl, CaCl, Al-Cl KCl can provide extra potassium for those taking

    diuretics

    KCl can be harmful if patient has renal insufficiency

    Lite salt contains sodium

    Some spices and herbs are low in sodium

    Others are high in sodium

    Classification of

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    62/65

    Classification ofAntihypertensive Drugs

    Diuretics

    Thiazides

    Loop diuretics

    Potassium-sparing diuretics Beta blockers (BB)

    Angiotensin II receptor blockers (ARBs)

    Alpha-beta blockers

    Alpha1 receptor blockers ACE inhibitors (angiotensin converting enzyme)

    Calcium antagonists

    Direct vasodilators

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    63/65

    Renin-Angiotensin Aldosterone System

    Angiotensinogen

    Non-ACE pathways(eg, chymase)

    Vasoconstriction

    Cell growth

    Na/H2O retention

    Sympathetic activation

    Renin Angiotensin I

    Angiotensin II

    ACE

    Cough,

    angioedema

    Benefits? Bradykinin

    Inactive

    fragments

    Vasodilation

    Antiproliferation

    (kinins)

    Aldosterone AT2

    AT1

    Lif t l M difi ti f P ti f

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    64/65

    Lifestyle Modifications for Prevention ofHypertension

    Lose weight if overweight

    Limit alcohol

    Increase physical activity

    Decrease sodium intake Keep potassium intake at adequate levels

    Take in adequate amounts of calcium and magnesium

    Decrease intake of saturated fat and cholesterol Stop smoking

  • 7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12

    65/65

    Summary

    Lifestyle modifications for prevention of hypertension

    quite effective!

    Management of hypertensionvery important to reduce

    risk of heart attack or stroke